Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial. [electronic resource]
Producer: 20180607Description: 122 p. digitalISSN:- 1471-2466
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Alveolitis, Extrinsic Allergic -- complications
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Connective Tissue Diseases -- complications
- Disease Progression
- Double-Blind Method
- Female
- Humans
- Lung -- physiopathology
- Male
- Middle Aged
- Pulmonary Fibrosis -- drug therapy
- Pyridones -- administration & dosage
- Research Design
- Treatment Outcome
- Vital Capacity -- drug effects
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.